Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach.
about
Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome researchClonal hematopoiesis in acquired aplastic anemiaLong-term outcome of isolated thrombocytopenia accompanied by hypocellular marrow.Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes.Myelodysplastic syndromes: Contemporary review and how we treat.The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failureGATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.Immunologic aspects of hypoplastic myelodysplastic syndrome.Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients.HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemiaDiagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.Recent advances in bone marrow biopsy pathology.Xist RNA is a potent suppressor of hematologic cancer in mice.Immunological derangement in hypocellular myelodysplastic syndromes.Recent advances in the diagnosis and classification of myeloid neoplasms--comments on the 2008 WHO classification.Standards and impact of hematopathology in myelodysplastic syndromes (MDS).How I manage aplastic anaemia in children.Diagnosis of acquired bone marrow failure syndrome during childhood using the 2008 World Health Organization classification system.Diagnosis of acquired aplastic anemia.Treatment of aplastic anaemia in elderly patients aged >60 years.Potential pathological and functional links between long noncoding RNAs and hematopoiesis.Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.I walk the line: how to tell MDS from other bone marrow failure conditions.Molecular pathology of myelodysplastic syndromes: new developments and implications for diagnosis and treatment.Importance of classical morphology in the diagnosis of myelodysplastic syndrome.Clinical significance of acquired somatic mutations in aplastic anaemia.Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasmFlow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.Diagnostics and Prognostication of Myelodysplastic Syndromes.Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia.ICSH guidelines for the standardization of bone marrow immunohistochemistry.The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs.Hypocellular acute myeloid leukemia treated with bone marrow transplantation.Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated?Guidelines for the diagnosis and management of adult myelodysplastic syndromes.Heterozygous variants in bone marrow failure and myeloid neoplasms
P2860
Q26859843-CF95D0A8-A494-44C3-9481-42DFDFDED79FQ28079733-AE41C3DF-82AA-44A5-865F-731E5F597411Q33396196-59A417F6-93BF-4722-9CAC-12C0B4957533Q33412937-00093CD5-3116-4E37-9923-B5D7A090ABF5Q33429195-4FC1B521-7395-4061-BAFB-A5242572C24BQ33829778-EFB3D096-4426-4AA7-8A3D-FFE44B094F18Q34802461-C2EE0748-5670-4F71-98EB-BF6BC15A83BDQ35252614-3B8932AD-F3CF-4EAC-8D76-631DA6EA9075Q35275808-9394BD4C-8BB6-4115-A64B-78B9566F96B9Q35717828-FF74525D-15C3-4C78-AFC8-DD52DDCD4438Q36772225-B0D96476-BAA9-4C16-98B6-5E68577B7638Q37263146-F821AA4D-6F63-4059-84D7-B46FC7DED350Q37301282-5A48D7CB-E537-47B9-B7BA-F1E6EF79095EQ37419610-12A46738-661C-43F7-BD7D-8A6020B691EBQ37724605-FD0A2439-7961-47FD-8060-3304C440424DQ37772200-19107B3B-AAAB-4642-BA97-5A1C3941ACB1Q37840934-C8625B92-7BC2-4459-B107-C13F0E5AC55FQ37986162-FAA160F6-7379-496D-B34A-4EA58FACD350Q38007876-CB5C4B67-B6E2-4846-B50A-FE0083D816FDQ38061043-F801AE62-0BF6-4712-AA9D-7D2023C8347AQ38062302-ACC42C54-19AE-436E-A395-8F6603DF26F8Q38130412-B51887DE-3E67-4C88-8E48-E2B998AE5B05Q38220788-D99616ED-0249-4DB6-8F18-745B2AA8F497Q38235622-0C81F161-689D-4991-9E13-2BE80E94158BQ38451022-AE63DB24-6E7F-4431-9F40-6C37CB783305Q38471249-97B659D2-D13D-4429-B6C0-B3ED47015D59Q38809618-86B4AC87-9DEA-4214-90D1-2B59135ECCC6Q39289359-CF1EB063-782A-4F95-9DDE-1A2595749AD8Q42662183-C69BA83B-CE67-4308-AC40-418CF8C6ED54Q42757406-88A25D5F-CD86-470A-80C3-CA3EB4574B41Q45761407-C7E1F30F-579C-4953-886F-4D23E5EB0E55Q46201774-BAE83453-CF7B-4B8F-9959-B694B1CA979BQ47101298-582D8405-D7CA-46B2-A841-B38BA257F58EQ52881805-6A4A8A89-7AA1-4634-AE02-3C93D7237D3DQ54043084-9E8F1D6F-9788-47B0-BB50-3655FD3A439EQ54392826-6B9D0573-7992-42EF-A5F0-17464CA090C8Q57754008-D0F60F6A-48A0-4E33-BA6A-33C2E35859CD
P2860
Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnostic criteria to disting ...... s for a standardized approach.
@en
Diagnostic criteria to disting ...... s for a standardized approach.
@nl
type
label
Diagnostic criteria to disting ...... s for a standardized approach.
@en
Diagnostic criteria to disting ...... s for a standardized approach.
@nl
prefLabel
Diagnostic criteria to disting ...... s for a standardized approach.
@en
Diagnostic criteria to disting ...... s for a standardized approach.
@nl
P2860
P356
P1433
P1476
Diagnostic criteria to disting ...... s for a standardized approach.
@en
P2093
Attilio Orazi
John M Bennett
P2860
P304
P356
10.3324/HAEMATOL.13755
P577
2009-01-14T00:00:00Z